Literature DB >> 19230128

TGFbeta affects collagen cross-linking independent of chondrocyte phenotype but strongly depending on physical environment.

Yvonne Maria Bastiaansen-Jenniskens1, Wendy Koevoet, Anton C W De Bart, Anne-Marie Zuurmond, Ruud A Bank, Jan A N Verhaar, Jeroen DeGroot, Gerjo J V M van Osch.   

Abstract

Transforming growth factor beta (TGFbeta) is often used in cartilage tissue engineering to increase matrix formation by cells with various phenotypes. However, adverse effects of TGFbeta, such as extensive crosslinking in cultured fibroblasts, have also been reported. Our goal was to study effects of TGFbeta on collagen cross-linking and evaluating the role of cellular phenotype and physical environment. We therefore used four different cell populations in two very different physical environments: primary and expanded chondrocytes and fibroblasts embedded in alginate gel and attached to tissue culture plastic. Matrix production, collagen cross-linking, and alpha-smooth muscle actin (alphaSMA) were analyzed during 4 weeks with or without 2.5 ng/ mL TGFbeta2. TGFbeta2 did not affect collagen deposition by primary cells. In expanded cells, TGFbeta2 increased collagen deposition. Chondrocytes and fibroblasts in monolayer produced more collagen cross-links with TGFbeta2. In alginate, primary and expanded cells displayed an unexpected decrease in collagen cross-linking with TGFbeta2. alphaSMA was not present in alginate cultures and barely upregulated by TGFbeta2. Organized alphaSMA fibers were present in all monolayer cultures and became more pronounced with TGFbeta2. This study demonstrates that the physical environment determined by the substrate used co-determines the response of cells to TGFbeta. The presence of mechanical stress, determined with alphaSMA-staining, is probably responsible for the increase in collagen cross-linking upon addition of TGFbeta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19230128     DOI: 10.1089/ten.tea.2007.0345

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   4.080


  7 in total

1.  Noninvasive multimodal evaluation of bioengineered cartilage constructs combining time-resolved fluorescence and ultrasound imaging.

Authors:  Brett Z Fite; Martin Decaris; Yinghua Sun; Yang Sun; Adrian Lam; Clark K L Ho; J Kent Leach; Laura Marcu
Journal:  Tissue Eng Part C Methods       Date:  2011-02-08       Impact factor: 3.056

2.  The response of foetal annulus fibrosus cells to growth factors: modulation of matrix synthesis by TGF-β1 and IGF-1.

Authors:  Anthony J Hayes; James R Ralphs
Journal:  Histochem Cell Biol       Date:  2011-07-08       Impact factor: 4.304

3.  TGF-β1 diminishes collagen production during long-term cyclic stretching of engineered connective tissue: implication of decreased ERK signaling.

Authors:  Zeeshan H Syedain; Robert T Tranquillo
Journal:  J Biomech       Date:  2011-01-20       Impact factor: 2.712

4.  Elevated Levels of Cartilage Oligomeric Matrix Protein during In Vitro Cartilage Matrix Generation Decrease Collagen Fibril Diameter.

Authors:  Y M Bastiaansen-Jenniskens; A C W de Bart; W Koevoet; K M B Jansen; J A N Verhaar; G J V M van Osch; J DeGroot
Journal:  Cartilage       Date:  2010-07       Impact factor: 4.634

5.  Optimization of a chondrogenic medium through the use of factorial design of experiments.

Authors:  Lars Enochson; Mats Brittberg; Anders Lindahl
Journal:  Biores Open Access       Date:  2012-12

Review 6.  The role of epigenetics in the fibrotic processes associated with glaucoma.

Authors:  Fiona McDonnell; Colm O'Brien; Deborah Wallace
Journal:  J Ophthalmol       Date:  2014-03-31       Impact factor: 1.909

Review 7.  Cartilage repair: past and future--lessons for regenerative medicine.

Authors:  Gerjo J V M van Osch; Mats Brittberg; James E Dennis; Yvonne M Bastiaansen-Jenniskens; Reinhold G Erben; Yrjö T Konttinen; Frank P Luyten
Journal:  J Cell Mol Med       Date:  2009-05-15       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.